ESR1 and breast cancer: Breast cancer produced in women with pathogenic BRCA1 variants tend to be estrogen receptor (ER)-negative and triple-negative4, exhibit genomic heterogeneity5, and lack phenotypic characteristics of the mature luminal cells of the normal adult female mammary gland6.